Comment On: Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome
- Alternative title
-
Comentários sobre Tratamento da miocardiopatia periparto com agonista dopaminérgico e subsequente gestação com resultado satisfatório
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Comment On: Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome ; volume:38 ; number:11 ; year:2016 ; pages:580-582
Revista brasileira de ginecologia e obstetrícia ; 38, Heft 11 (2016), 580-582
- Contributor
- DOI
-
10.1055/s-0036-1594305
- URN
-
urn:nbn:de:101:1-2019011408260787768879
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Triebel, Jakob
- Clapp, Carmen
- Bertsch, Thomas
Other Objects (12)
Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
MicroRNAs in Dopamine Agonist-Resistant Prolactinoma
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Dopamine agonist resistant prolactinomas: any alternative medical treatment?
Predictors of dopamine agonist resistance in prolactinoma patients
Peripartum cardiomyopathy
Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas
Peripartum Cardiomyopathy with Respiratory Failure and Cardiac Arrest
Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
MicroRNAs in Dopamine Agonist-Resistant Prolactinoma
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Dopamine agonist resistant prolactinomas: any alternative medical treatment?
Predictors of dopamine agonist resistance in prolactinoma patients
Peripartum cardiomyopathy
Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas
Peripartum Cardiomyopathy with Respiratory Failure and Cardiac Arrest
Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
MicroRNAs in Dopamine Agonist-Resistant Prolactinoma
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Dopamine agonist resistant prolactinomas: any alternative medical treatment?
Predictors of dopamine agonist resistance in prolactinoma patients
Peripartum cardiomyopathy
Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas